Jci_page_head_homepage_01 Jci_page_head_homepage_02
Stephan Grabbe, Georg Varga, Stefan Beissert, Meike Steinert, Gunther Pendl, Stephan Seeliger, Wilhelm Bloch, Thorsten Peters, Thomas Schwarz, Cord Sunderkötter, Karin Scharffetter-Kochanek
Published in Volume 109, Issue 2
J Clin Invest. 2002; 109(2):183–192 doi:10.1172/JCI11703
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 9

LCs in WT and CD18–/– mice. (a) Mice that were either left untreated, or were treated with topical mometasone-17-(2-furoate) 5 days or 25 days prior to assessment of LC density. Ear skin was obtained, and epidermal sheets were prepared and stained for I-A+ epidermal cells, as described in Methods. (b) Ears were treated with the fluorescent hapten FITC. Regional LNs were prepared 18 hours later, and LN cells were stained with phycoerythrin-labeled anti–I-A antibodies and subjected to flow cytometry. LCs were gated based on FSC/SSC characteristics. Numbers in boxes indicate the percentage of double positive cells.